Yagasaki Hiroshi, Mugishima Hideo
Department of Pediatrics, Nihon University School of Medicine.
Nihon Rinsho. 2009 Oct;67(10):1884-8.
Hematological malignancy is known to be associated with Down syndrome (DS), neurofibromatosis type 1 (NF1) and congenital bone marrow failure syndromes (CBMFS). Although many responsible germ-cell mutations have been identified, the secondary mutations that are responsible for the development of myelodysplastic syndrome and acute myelogenous leukemia (MDS/AML) have not been determined. Additional chromosomal abnormalities such as monosomy 7 and trisomy 21 are often observed in the progression to MDS/AML, and the critical genes for monosomy 7 have recently been reported. In this review, we briefly present recent findings regarding DS, NF1 and CBMFS with a tendency for malignant transformation; Fanconi anemia, familial platelet disorder with propensity to myeloid malignancy and congenital severe neutropenia.
已知血液系统恶性肿瘤与唐氏综合征(DS)、1型神经纤维瘤病(NF1)和先天性骨髓衰竭综合征(CBMFS)有关。尽管已经鉴定出许多致病的生殖细胞突变,但导致骨髓增生异常综合征和急性髓系白血病(MDS/AML)发生的继发突变尚未确定。在进展为MDS/AML的过程中,常观察到其他染色体异常,如7号染色体单体和21号染色体三体,并且最近已经报道了7号染色体单体的关键基因。在本综述中,我们简要介绍了关于DS、NF1和具有恶性转化倾向的CBMFS的最新研究结果;范可尼贫血、易患髓系恶性肿瘤的家族性血小板疾病和先天性严重中性粒细胞减少症。